Amphion Innovations plc

Placing to Raise £ 1.54 million

London and New York, 5 June 2015 - Amphion Innovations plc (LSE: AMP) ("Amphion" or the "Company"), the developer of medical and technology businesses, is pleased to announce that the Company has raised £1,538,840 (before expenses) by the issue of 29,311,230 new ordinary shares of 1p each in the capital of the Company (the "New Ordinary Shares") at an issue price of 5.25 pence per New Ordinary Share (the “Placing”). The New Ordinary Shares represent approximately 14.91 per cent of the Company’s enlarged issued share capital.  The Placing, which was oversubscribed, was undertaken by Northland Capital Partners Limited and the issue price of 5.25 pence represents a 22.4 per cent. discount to the Company’s 10 day average closing price.

The net proceeds of the Placing will provide working capital for the Company, as well as enable the Company to invest in current Partner Companies, restructure its existing debt, and support DataTern’s patent litigation programmes.

Application will be made to the London Stock Exchange for the New Ordinary Shares to be admitted to trading on AIM (“Admission”).  The New Ordinary Shares will, when issued, rank equally in all respects with the existing Ordinary Shares.  It is expected that Admission will become effective and that dealings in the New Ordinary Shares will commence on 10 June 2015.

Following the Admission of the 29,311,230 New Ordinary Shares, the Company will have 196,620,573 ordinary shares in issue with each ordinary share holding one voting right.

For further information please contact

Amphion Innovations
Charlie Morgan
+1 212 210 6224

Yellow Jersey PR
Dominic Barretto / Fiona Walker
+44 7768 537 739

Panmure Gordon Limited (Nominated Advisor and Joint Corporate Broker)
Freddy Crossley / Fred Walsh (Corporate Finance)
Charlie Leigh-Pemberton (Corporate Broking)
+44 020 7886 2500

Northland Capital Partners Limited (Joint Corporate Broker)
Gerry Beaney/ David Hignell (Corporate Finance)
John Howes/ Mark Treharne (Corporate Broking)
+44 020 7382 1100

Plumtree Capital Limited (Advisor to Amphion)
Stephen Austin
+44 020 7183 2493
+646 568 7502

About Amphion Innovations plc
Amphion Innovations is a developer of medical, life science and technology businesses.

We use our extensive experience in company building to invest and build shareholder value in high growth companies in the US and UK. Amphion has significant shareholding in 7 Partner Companies developing proven technologies targeting substantial commercial marketplaces. The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the Partner Companies. The Partner Companies collectively own or control over 200 separately identified pieces of intellectual property, a number which grows rapidly each year.

On the web: